lipid loci explained the association signal or were independent evidence of functional genes. Finally, we examined whether exome data implicated the same putatively functional genes at lipid loci in both European and East Asian cohorts.
RESULTS
To improve the coverage for the low-frequency variants in Asian populations and follow up on various GWAS variants, we added approximately 60,000 custom-content variants to the standard exome array. Among 319,272 variants that passed quality control, 204,408 (64.0%) were polymorphic in East Asian individuals, of which about 25% (50,126) were from the custom content. Approximately 76.1% (155,566) of the polymorphic variants were annotated as nonsynonymous or loss-of-function (stop-gain, stop-loss, and splice variants) ( Supplementary Table 1 ). By determining the proportion of variants observed in Exome Aggregation Consortium (ExAC) East Asian samples (n = 4,327 individuals) that were successfully genotyped by the array, we estimated that the exome array captured a large fraction of common and low-frequency coding variants (71.15% and 72.59% for variants with minor allele frequency (MAF) > 5% and MAF = 1-5%, respectively). Among rare coding variants identified in ExACsequenced individuals, 59.91% (MAF = 0.1-1%) and 19.92% (two or more copies) were captured by the array. Therefore, the array provided good coverage for low-frequency variants and moderate coverage for rare coding variants in East Asians. In addition, we examined 76,000 polymorphic coding variants that were unavailable or monomorphic in ExAC East Asian samples.
Discovery of novel variants associated with lipid levels
Our analysis identified three variants with study-wide significance in three novel loci in East Asians, located at least 1 Mb from previously reported GWAS signals of lipid levels ( Table 1) . These were rs4377290 in ACVR1C (TC; P = 4.69 × 10 −8 ), rs7901016 in MCU (LDL-C; P = 5.12 × 10 −9 ), and the missense variant rs4883263 (encoding p.Ile342Val) in CD163 (HDL-C; P = 5.24 × 10 −11 ). Each of these three variants demonstrated evidence for association (P = 1.80 × 10 −3 to 6.68 × 10 −5 ) in over 300,000 GLGC individuals.
Summary of association results
We assessed the association of 110,986 polymorphic variants that had at least 20 minor alleles in 47,532 East Asian samples. Overall, we detected 255 variants (including 51 coding variants) at 41 loci with exome-wide significant association with one or more lipid traits (P < 4.5 × 10 −7 ), of which 3 loci had not been previously reported (Fig. 1) . Collectively, the overall variance in each lipid trait that could be explained by exome-wide significant variants in East Asian samples was 5.97% for TC, 6.20% for LDL-C, 6.93% for HDL-C, and 6.89% for TG levels, of which 3.22%, 4.77%, 3.35%, and 3.86%, respectively, could be attributed to coding variants (Fig. 2) . Our results also showed that an additional seven known loci were associated with lipid levels with suggestive significance (P < 4.46 × 10 −6 , Bonferroni correction of 11,215 variants) (Supplementary Table 2 ), and that, taken together, they increased the percentage of trait variance explained to 6.08-7.20%.
Evaluation of known lipid signals
Among the 38 previously established lipid loci that reached significance, we identified a more significant candidate variant at 14 loci ( Supplementary Table 3 and Fig. 1 ) where the initially reported GWAS index variants showed no significant associations or were independent of our lead variants (r 2 < 0.02) (APOB and APOE), demonstrating allelic heterogeneity between people of East Asian ancestry and those of European ancestry. The lead variants in the remaining 24 loci were the same as or strongly related to (r 2 > 0.69) the reported GWAS index variants from previous studies in primarily European samples. Sequential conditional analyses showed that 12 loci with evidence of association had two or more significant signals ( Supplementary Table 4 ). For example, we detected a novel missense variant (rs2075260, encoding p.Val2141Ile) at ACACB that was largely independent of the originally reported GWAS index variant rs7134594 at MVK (r 2 = 0.01) 2 , and thus represented a previously unreported association. The GWAS index variant rs7134594 could be explained by another missense variant (rs9593, encoding p.Met239Lys) at MMAB (conditional P = 0.73).
In gene-based analysis, nine genes (PCSK9, EVI5, HMGCR, CD36, APOA1, PCSK7, CETP, LDLR, and PPARA) reached genebased significance (P < 2.8 × 10 −6 ) in connection with lipid levels ( Supplementary Fig. 1 and Supplementary Table 5 ). However, our gene-based analyses did not identify any new genes that had not already been highlighted by single-variant tests.
Putative functional coding variants at known loci
The identification of coding variants in known loci has the potential to pinpoint causal genes. We observed that the protein-altering variants were more likely to have strong effect sizes with regard to lipid levels ( Fig. 3 and Supplementary Table 6 ) compared with the noncoding variants that were significantly associated with lipid levels. Ten coding variants in eight genes showed strong effects on lipid levels (β-coefficients ranging from 0.20 to 1.17 s.d.), and eight were low-frequency or rare variants (MAF < 3%). We next sought to quantify what proportion of GWAS loci might be due to a protein-altering variant, and thus implicate a candidate functional gene. We made the reasonably well-supported assumption that a protein-altering variant that is the top signal, explains the signal, or is independent of the original signal is the most likely causal variant for each region [15] [16] [17] . Among the 38 known loci for which association evidence attained study-wide significance, 12 loci harbored a protein-altering variant that showed the strongest association with lipid levels, and 4 loci had a proteinaltering variant that was not the top signal but could explain the association of the reported index variant ( Supplementary Table 7 and Fig. 1 ). In 8 of these 16 loci (PCSK9, EVI5, CD36, MMAB, ALDH2, SLC12A4, LDLR, and PPARA), the previously identified lead variants in European populations did not reach exome-wide significance. Figure 1 Exome-wide association results for 47,532 East Asians. The Manhattan plots show -log 10 P values for variants associated with LDL-C, HDL-C, TC, and TG. Signals with exome-wide significance (horizontal dashed lines; P < 4.5 × 10 −7 ) are highlighted, and the previously reported GWAS lead variants of each region are indicated by diamonds. East Asian-specific variants are defined as variants with conditional P values that reached exomewide significance after conditioning on all independent variants in the corresponding loci identified by GLGC exome-wide association studies.
the original signal but may highlight functional genes in the region. All of these putative functional variants may point to functional candidate genes-either well-established causal genes (such as the genes that cause Mendelian dyslipidemias ( Supplementary Table 8 )) or potential new candidate genes (MMAB, ACACB, SLC12A4, and PMFBP1). In total, the 31 protein-altering variants in the known loci may point to 25 candidate functional lipid genes.
Association with coronary artery disease
To further evaluate whether the novel variants and putative functional variants in known regions identified in our samples also influenced CAD risk, we tested for association in 28,899 Chinese individuals with and without coronary disease (9,661 CAD cases and 18,558 controls) and in the largest publicly available CAD GWAS analysis (CARDIoGRAMplusC4D),which includes ~185,000 CAD cases and controls 18 ( Supplementary Table 9 ). For the novel noncoding variant near MCU (rs7901016), the C allele associated with lower levels of LDL-C was similarly associated with reduced risk for CAD in Chinese samples (odds ratio (OR) = 0.94; 95% confidence interval (CI) = 0.90-0.98; P = 2.8 × 10 −3 ) and CARDIoGRAMplusC4D samples (OR = 0.94; 95% CI = 0.91-0.98; P = 4.55 × 10 −4 ). Among the 31 putative functional coding variants in the known regions, all 20 non-HDL-C-related variants showed a consistent direction of effect between lipid traits and CAD. Fifteen out of 20 showed nominal significance (P < 0.05) in Chinese or CARDIoGRAMplusC4D CAD data, whereas 7 variants in PCSK9, APOB, LDLR, APOE, HNF1A, and APOA5 showed significant associations even after multiple testing was accounted for (P values ranged from 5.95 × 10 −4 to 8.17 × 10 −11 < 0.05/31). In particular, nearly all of the LDL-associated coding variants demonstrated association with CAD, and the strengths of effect on CAD risk and LDL-C level were strongly correlated (r 2 = 0.78; P = 3.3 × 10 −4 ; Supplementary Fig. 2 ).
Novel loci identified in East Asian and GLGC samples
An exome-wide association screen for plasma lipids in >300,000 individuals genotyped by exome array was conducted in parallel by the GLGC 14 . The majority (84%) of the participants were of European ancestry, and only 2.3% were of East Asian ancestry. We further carried out a large-scale trans-ancestry meta-analysis of our East Asian and GLGC samples, being careful to include overlapping samples only once, to seek both novel and population-specific genetic variants for lipid levels.
In the combined GLGC and East Asian samples, nine additional variants that were not significant in the East Asian or GLGC analyses showed significant association (P < 2.1 × 10 −7 , Bonferroni correction of 242,289 variants analyzed by the GLGC) with at least one lipid trait. All of them were common (MAF > 0.05 in both East Asian and GLGC samples), including four coding variants ( Table 2 and Supplementary  Fig. 3 ): FAM114A2 (p.Gly122Ser; HDL-C; P = 1.74 × 10 −7 ), MGAT1 (p.Leu435Pro; HDL-C; P = 9.36 × 10 −8 ), ASCC3 (p.Leu146Phe; LDL-C, P = 5.84 × 10 −8 ; TC, P = 5.22 × 10 −9 ), and PLCE1 (p.Arg1575Pro; TC; P = 9.92 × 10 −8 ).
Joint analysis of novel signals with additional samples
To strengthen support for the observed associations, we carried out in silico replication of significant variants in three additional independent genome-wide data sets comprising a combined total of ~160,000 individuals from the Nord-Trøndelag Health Study 19 , GLGC GWAS samples 2 , and a Chinese lipids GWAS 20 . We found that the associations of 12 novel variants achieved greater significance than in the discovery study and reached genome-wide significance in the joint analysis (P values ranged from 3.0 × 10 −8 to 7.6 × 10 −15 ) ( Supplementary Table 10 ).
Coding variants point to the same genes across ancestries
We further evaluated whether the variants identified in East Asian samples were also defined as putative functional variants in GLGC samples ( Supplementary Table 11 ). We found that East Asian and GLGC samples both pointed to the same nine functional genes, but that different associated variants were present in each ancestry ( Table 3 ). The eight coding variants (MAF, 0.004-15.9%) at PCSK9, CD36, ABCA1, CETP, PMFBP1, LIPG, LDLR, and PPARA identified by GLGC showed lower MAFs (0-2.57%) in the East Asian samples and thus achieved no or only suggestive significance (CETP). Conversely, the coding variants at PCSK9, APOB, CD36, CETP, LDLR, and PPARA identified in East Asian samples (MAF, 0.094-12.45%) also had lower MAFs in GLGC samples (0.001-0.20%). In addition, the same putatively functional coding variants and genes at seven loci (GCKR, MLXIPL, LPL, GPAM, HNF1A, TM6SF2, and APOE) were identified in both East Asian and GLGC samples, with similar common MAFs ( Table 4 ).
East Asian-specific association signals
We next attempted to identify variants that were associated with lipids in East Asian samples only. Among the known lipid loci, we identified 363 independent variants by sequential conditional analysis in GLGC exome-wide association studies ( Supplementary Table 11 ). After conditioning on the independent variants in the corresponding loci, we identified 14 independent coding variant associations at 11 loci in East Asian samples with conditional P values < 4.5 × 10 −7 ( Table  5 , Figs. 1 and 3) . All 14 East Asian-specific variants were included in the list of putative functional variants that we identified. Eight of these loci (EVI5, APOB, HMGCR, CD36, APOA1, CETP, LDLR, and PPARA) harbored at least one low-frequency or rare independent coding variant (MAF, 4.21-0.03%). All of these variants either were monomorphic or had a frequency that was at least one order of magnitude lower in Europeans and thus showed only suggestive significance in ~300,000 GLGC individuals.
DISCUSSION
This study represents a large discovery effort to identify coding variation that influences lipid levels in the East Asian population, and it enabled us to systemically evaluate protein-altering variants that identify candidate functional genes. Meta-analyses of East Asian and multi-ancestry samples by exome-chip genotyping array identified 12 novel loci, 5 of which harbored nonsynonymous variants. In the 38 known loci that were replicated, we identified 31 protein-altering variants pointing to 25 functional lipid genes. Moreover, significant association with protein-altering variants identified the same 16 putative functional genes in European and East Asian samples, and 9 of those genes were identified by independent protein-altering variants in the two ancestries. Among the novel genetic loci identified, several have been implicated in cardiovascular and metabolic phenotypes, which may provide mechanistic insight into the regulation of lipid levels and potential targets for treatment. The significant novel variant associated with both lipids and CAD is located in an intron of MCU. MCU encodes a mitochondrial inner membrane calcium uniporter that mediates calcium uptake into mitochondria. Mitochondrial calcium has an important role in the regulation of metabolism in the heart 21 . CD163 encodes a macrophage-specific receptor involved in the clearance and endocytosis of hemoglobin-haptoglobin complexes by macrophages. Soluble CD163 was recently proposed as a biomarker of the well-known variables of metabolic syndrome, including HDL-C 22 . ACVR1C encodes activin-receptor-like kinase 7 (ALK7), one of the type I transforming growth factor-β receptors. ALK7 has recently been shown to have an important role in the maintenance of metabolic homeostasis 23 . ALK7 is expressed at high levels in human adipose tissue and is correlated with body fat and lipids. ALK7 dysfunction may cause increased lipolysis in adipocytes and leads to decreased fat accumulation. MGAT1 encodes mannosyl (α-1,3)-glycoprotein β-1,2-N-acetylglucosaminyltransferase, which is involved in the synthesis of protein-bound and lipid-bound oligosaccharides. It has been found that a variant of MGAT1 is associated with body weight and obesity 24 . We note that CD163 and PDGFC were associated with lipid levels in an East Asian lipids GWAS meta-analysis published after our manuscript was submitted 25 . To further clarify the possible transcriptional mechanisms underlying the identified loci in association with lipids, we investigated the relationships of the novel variants and proxies with expression quantitative trait loci (eQTLs) by using the Genotype-Tissue Expression (GTEx) eQTL browser. We found significant cis-eQTL effects in human tissues at five loci at P < 4.5 × 10 −7 ( Supplementary Table 12 ). We further predicted putatively regulatory variants in seven novel noncoding regions in 81 cell lines on the basis of deltaSVM scores 26 , and found that the variants in PDGFC, C6orf183, and MCU had high regulatory potential with extreme deltaSVM scores greater than 10 in absolute value (Supplementary Fig. 4) .
Our data allow a more comprehensive understanding of the genetic architecture of lipid susceptibility by revealing novel lipid genes and identifying allelic heterogeneity across populations of different ancestries. We detected multiple independent association signals or new lead variants in known lipid-associated loci that frequently showed no or moderate LD with the corresponding GWAS index variants in European populations. Specifically, we identified 14 East Asian-specific variants that could not be explained by all the independent variants in the corresponding loci identified in GLGC samples. Our study demonstrated the benefits of distinct LD patterns between ancestry groups for the investigation of validated loci. We also found substantial inter-ancestry differences in the identification of rare coding variants across populations, which may have been subjected to natural selection during human evolution or genetic drift. All the low-frequency or rare functional coding variants identified in East Asians (MAF, 0.03-4.21%) appeared to be population specific, and were monomorphic or not present in European individuals who were part of the 1000 Genomes Project; this allelic heterogeneity across populations of different ancestry has been reported in part 6, 11 . However, we observed that these rare variants were not monomorphic in more than 300,000 GLGC individuals, but had 15-fold to 160-fold lower frequencies (MAF, 0.001-0.15%) in Europeans than in East Asians ( Supplementary  Table 13 and Supplementary Fig. 5) , with little power to indicate association in Europeans. Similarly, the low-frequency and rare coding variants identified in GLGC samples were extremely rare or monomorphic in East Asian samples ( Supplementary  Fig. 6 and Supplementary Table 11 ). Overall, our findings demonstrate that rare and low-frequency coding variants are more likely to be population specific, which underscores the value of discovering ancestry-specific rare variants in diverse populations, particularly for low-frequency variations.
As most GWAS index variants are located in noncoding regions, the identification of associated protein-coding variants may allow scientists to prioritize functional genes and variation. Among the 38 known loci that reached chip-wide significance in our data, coding variants at 16 loci (42.1%) were found to completely account for the original association signal. At an additional nine loci, an independent protein-altering variant indicated a likely functional gene. The coding variants were more likely to have consistent effect sizes across ethnic groups than noncoding variants were. For the GWAS index variants that could not be replicated in East Asian samples, the effect sizes were poorly correlated with those observed in Europeans. In contrast, the effect sizes of the putatively functional coding variants in the same loci were strongly related across ethnic groups (Supplementary Fig.  7) . Trans-ancestry comparisons provided additional credible evidence to support the identification of the same 16 genes as putative functional genes. The functional genes pointed to by coding variants were either well-known genes or genes with previously unknown roles in lipid metabolism (such as GPAM and PMFBP1), which may be good candidates for functional assessment. More important, we found that the effects of these putative functional coding variants on levels of LDL-C, TG, and TC were highly correlated with the effect on CAD, but the effects on HDL-C levels were not correlated with CAD. Our findings are in agreement with recent genetic studies showing that both LDL-C and TG levels, but not HDL-C levels, are causally related to CAD risk [27] [28] [29] [30] .
This large-scale exome-wide association study allowed us to detect a greater number of low-frequency and rare variants than previously identified, 30% of which were not polymorphic in an earlier exomewide study involving 12,685 Chinese individuals 11 . Nonetheless, the exome array offered moderate coverage for rare variants observed in ExAC East Asian samples. Power calculations indicated that the available sample size provided 80% power to detect variants with an effect size of 0.27 s.d. and MAFs as low as 0.5% at P < 4.5 × 10 −7 . However, we had considerably less power to evaluate extremely rare variants (MAF < 0.1%). Studies with larger sample sizes and of sequenced samples are therefore needed to fully investigate associations of rare variants with lipid levels.
In conclusion, we identified 12 new loci associated with lipid levels. We also identified coding variants that highlight 25 likely functional genes at previously known loci, including several with previously undiscovered roles in lipids. We also found an abundance of population-specific coding variant associations that underlie lipid traits, highlighting the importance of including individuals of diverse ancestral backgrounds. At the same time, our data demonstrate that the integration of genomic data across diverse ancestral groups may enable researchers to identify functional variants and genes for further functional study.
URLs. Genotype-Tissue Expression (GTEx) Portal, http://www. gtexportal.org/home; Genezoom, http://genome.sph.umich.edu/ wiki/Genezoom; ExAC, http://exac.broadinstitute.org; RareMETALS, http://genome.sph.umich.edu/wiki/RareMETALS; RVTESTS, http:// genome.sph.umich.edu/wiki/RvTests; RAREMETALWORKER, http://genome.sph.umich.edu/wiki/RAREMETALWORKER.
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